VRNA vs CTAS

Comparison between Verona Pharma Plc (VRNA, Company) and Cintas Corporation (CTAS, Company).

VRNA is from the Healthcare sector, while CTAS is from the Industrials sector.

5-Year PerformanceVRNA has outperformed CTAS, delivering a return of +77.1% compared to +16.4%

VRNA vs CTAS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	VRNA(COMPANY)	CTAS(COMPANY)
Market Cap	$78B	$77B
Max Drawdown	89.71%	67.75%
Sharpe Ratio	2.69	-0.46
5Y Beta	N/A	0.56
Industry	Biotechnology	Specialty Business Services
P/E Ratio	-852.67	39.86
Forward P/E	N/A	36.90
PEG Ratio	N/A	4.15
Dividend Yield	N/A	0.89%
5Y Dividends CAGR	N/A	11.82%
5Y EPS CAGR	N/A	15.38%
Debt to Equity	87.12%	55.48%
Free Cash Flow Yield	-0.09%	2.33%
P/S Ratio	350.73	6.98
P/B Ratio	279.39	15.40

Market Cap

Winner

VRNA

$78B

CTAS

$77B

Max Drawdown

VRNA

89.71%

Winner

CTAS

67.75%

Sharpe Ratio

Winner

VRNA

2.69

CTAS

-0.46

5Y Beta

VRNA

N/A

CTAS

0.56

Industry

VRNA

Biotechnology

CTAS

Specialty Business Services

P/E Ratio

Winner

VRNA

-852.67

CTAS

39.86

Forward P/E

VRNA

N/A

CTAS

36.90

PEG Ratio

VRNA

N/A

CTAS

4.15

Dividend Yield

VRNA

N/A

CTAS

0.89%

5Y Dividends CAGR

VRNA

N/A

CTAS

11.82%

5Y EPS CAGR

VRNA

N/A

CTAS

15.38%

Debt to Equity

VRNA

87.12%

Winner

CTAS

55.48%

Free Cash Flow Yield

VRNA

-0.09%

Winner

CTAS

2.33%

P/S Ratio

VRNA

350.73

Winner

CTAS

6.98

P/B Ratio

VRNA

279.39

Winner

CTAS

15.40

VRNA vs CTAS - Historical Returns

Returns include dividend reinvestment.

Period	VRNA	CTAS
1 month	+0.57%	+18.27%
3 months	+17.23%	+14.01%
6 months	+96.89%	+3.07%
1 year	+233.57%	-8.59%
5 years(CAGR)	+77.09%	+16.45%
10 years(CAGR)	+27.76%	+23.58%
Max(CAGR)	+27.76%	+13.14%

VRNA

+0.57%

Winner

CTAS

+18.27%

Winner

VRNA

+17.23%

CTAS

+14.01%

Winner

VRNA

+96.89%

CTAS

+3.07%

Winner

VRNA

+233.57%

CTAS

-8.59%

5Y(CAGR)

Winner

VRNA

+77.09%

CTAS

+16.45%

10Y(CAGR)

Winner

VRNA

+27.76%

CTAS

+23.58%

Max(CAGR)

Winner

VRNA

+27.76%

CTAS

+13.14%

VRNA vs CTAS - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	VRNA	CTAS
2026	N/A	+8.94%
2025	+121.80%	+4.13%
2024	+146.89%	+24.46%
2023	-18.79%	+35.60%
2022	+275.43%	+7.60%
2021	-5.35%	+30.13%
2020	+23.35%	+31.88%
2019	-40.41%	+62.22%
2018	-21.80%	+8.31%
2017	-12.07%	+35.46%
2016	N/A	+32.58%
2015	N/A	+17.39%
2014	N/A	+36.02%
2013	N/A	+43.96%
2012	N/A	+17.86%
2011	N/A	+26.66%
2010	N/A	+9.94%
2009	N/A	+11.53%
2008	N/A	-27.16%
2007	N/A	-16.06%
2006	N/A	-3.44%
2005	N/A	-4.02%
2004	N/A	-11.61%
2003	N/A	+7.44%
2002	N/A	-5.38%
2001	N/A	-4.28%
2000	N/A	+53.86%
1999	N/A	-12.73%

VRNA vs CTAS Drawdown Comparison

The maximum drawdown for VRNA was -89.71%, occurring on Mar 18, 2020. Recovery took 1189 trading sessions.

The maximum drawdown for CTAS was -65.30%, occurring on Mar 9, 2009. Recovery took 2829 trading sessions.

The current CTAS drawdown is -11.13%.

Rank	VRNA	CTAS
#1	-89.71% Apr 4, 2018 - Dec 21, 2022	-65.30% May 14, 2002 - Aug 8, 2013
#2	-56.07% Dec 30, 2022 - Aug 13, 2024	-48.38% Feb 19, 2020 - Jul 29, 2020
#3	-36.28% Sep 11, 2017 - Mar 15, 2018	-39.89% Nov 1, 1999 - Apr 4, 2000
#4	-29.89% May 23, 2017 - Sep 7, 2017	-36.22% Dec 26, 2000 - May 7, 2002
#5	-22.59% Feb 28, 2025 - Apr 29, 2025	-27.67% Jun 6, 2025 - May 13, 2026
#6	-13.51% Apr 29, 2025 - May 20, 2025	-27.09% Sep 6, 2018 - Apr 24, 2019
#7	-12.37% Nov 11, 2024 - Nov 27, 2024	-23.85% Dec 10, 2021 - Nov 22, 2022
#8	-10.66% Jun 24, 2025 - Jul 9, 2025	-23.77% Jun 2, 2000 - Nov 7, 2000
#9	-10.54% Mar 26, 2018 - Apr 4, 2018	-19.60% Nov 26, 2024 - May 27, 2025
#10	-8.78% Jan 7, 2025 - Jan 15, 2025	-16.42% Apr 4, 2000 - Apr 25, 2000
#11	-8.36% Sep 16, 2024 - Oct 3, 2024	-13.75% Dec 1, 2015 - May 24, 2016
#12	-8.20% Feb 21, 2025 - Feb 28, 2025	-13.73% Nov 27, 2000 - Dec 26, 2000
#13	-7.93% Mar 20, 2018 - Mar 26, 2018	-13.71% Nov 16, 2020 - Jun 22, 2021
#14	-7.47% Dec 27, 2022 - Dec 29, 2022	-12.80% Sep 6, 2016 - Dec 5, 2016
#15	-7.07% Aug 21, 2024 - Sep 10, 2024	-12.41% May 16, 2000 - May 30, 2000